Literature DB >> 12651044

Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.

Barry J Maron1, Kevin P Carney, Harry M Lever, Jannet F Lewis, Ivan Barac, Susan A Casey, Mark V Sherrid.   

Abstract

OBJECTIVES: The goal of this study was to determine the impact of race on identification of hypertrophic cardiomyopathy (HCM).
BACKGROUND: Sudden death in young competitive athletes is due to a variety of cardiovascular diseases (CVDs) and, most commonly, HCM. These catastrophes have become an important issue for African Americans, although HCM has been previously regarded as rare in this segment of the U.S. population.
METHODS: We studied the relationship of race to the prevalence of CVDs causing sudden death in our national athlete registry, and compared these findings with a representative multicenter hospital-based cohort of patients with HCM.
RESULTS: Of 584 athlete deaths, 286 were documented to be due to CVD at ages 17 +/- 3 years; 156 (55%) were white, and 120 (42%) were African American. Most were male (90%), and 67% participated in basketball and football. Among the 286 cardiovascular deaths, most were due to HCM (n = 102; 36%) or anomalous coronary artery of wrong sinus origin (n = 37; 13%). Of the athletes who died of HCM, 42 (41%) were white, but 56 (55%) were African American. In contrast, of 1,986 clinically identified HCM patients, only 158 (8%) were African American (p < 0.001).
CONCLUSIONS: In this autopsy series, HCM represented a common cause of sudden death in young and previously undiagnosed African American male athletes, in sharp contrast with the infrequent clinical identification of HCM in a hospital-based population (i.e., by seven-fold). This discrepancy suggests that many HCM cases go unrecognized in the African American community, underscoring the need for enhanced clinical recognition of HCM to create the opportunity for preventive measures to be employed in high-risk patients with this complex disease.

Entities:  

Mesh:

Year:  2003        PMID: 12651044     DOI: 10.1016/s0735-1097(02)02976-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  54 in total

Review 1.  Is the 'athlete's heart' arrhythmogenic? Implications for sudden cardiac death.

Authors:  Thomas Rowland
Journal:  Sports Med       Date:  2011-05-01       Impact factor: 11.136

2.  Ethnic differences in ventricular hypertrabeculation on cardiac MRI in elite football players.

Authors:  T Luijkx; M J Cramer; A Zaidi; R Rienks; P J Senden; S Sharma; F J van Hellemondt; C F Buckens; W P Mali; B K Velthuis
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

3.  Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance.

Authors:  B J Maron
Journal:  Heart       Date:  2005-11       Impact factor: 5.994

4.  Periodical cardiovascular screening is mandatory for elite athletes.

Authors:  H Inklaar; N M Panhuyzen-Goedkoop
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

5.  Isolated left ventricular noncompaction: clinical profile and prognosis in 106 adult patients.

Authors:  Tao Tian; Yaxin Liu; Linggen Gao; Jizheng Wang; Kai Sun; Yubao Zou; Linping Wang; Lin Zhang; Yuehua Li; Yan Xiao; Lei Song; Xianliang Zhou
Journal:  Heart Vessels       Date:  2013-10-02       Impact factor: 2.037

6.  A Rare Presentation of Angina and Arrhythmia in Absent Left Main Coronary Artery.

Authors:  Shoaib Ashraf; Syeda Hafsah Salman; Nisha Ali; Sarthak Kulshreshtha; Muhammad Saad
Journal:  Cureus       Date:  2020-12-18

7.  Detection and Classification of Hard and Soft Sweeps from Unphased Genotypes by Multilocus Genotype Identity.

Authors:  Alexandre M Harris; Nandita R Garud; Michael DeGiorgio
Journal:  Genetics       Date:  2018-10-12       Impact factor: 4.562

8.  Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart.

Authors:  C L Hertz; S L Christiansen; L Ferrero-Miliani; M Dahl; P E Weeke; G L Ottesen; R Frank-Hansen; H Bundgaard; N Morling
Journal:  Int J Legal Med       Date:  2015-09-17       Impact factor: 2.686

9.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Authors:  Jonathan G Howlett; Robert S McKelvie; J Malcolm O Arnold; Jeannine Costigan; Paul Dorian; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Philip Jong; Simon Kouz; Peter Liu; Elizabeth Mann; Gordon W Moe; Ross T Tsuyuki; Heather J Ross; Michel White
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

10.  Exome sequencing identifies a novel MYH7 p.G407C mutation responsible for familial hypertrophic cardiomyopathy.

Authors:  Qianqian Guo; Yuejuan Xu; Xike Wang; Ying Guo; Rang Xu; Kun Sun; Sun Chen
Journal:  DNA Cell Biol       Date:  2014-06-25       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.